» Articles » PMID: 12857931

E4orf3 is Necessary for Enhanced S-phase Replication of Cell Cycle-restricted Subgroup C Adenoviruses

Overview
Journal J Virol
Date 2003 Jul 15
PMID 12857931
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

E1B-55K-mutant or E4orf6-mutant adenoviruses replicate more effectively after infecting cells in S phase than after infecting cells in G(1). Enhanced S-phase replication of the E4orf6-mutant viruses requires the E4orf3 gene. This report demonstrates that the E4orf3 gene is also required for enhanced S-phase replication of the E1B-55K-mutant virus.

Citing Articles

The adenoviral E4orf3/4 is a regulatory polypeptide with cell transforming properties in vitro.

Ip W, Bertzbach L, Speiseder T, Dobner T Tumour Virus Res. 2023; 15:200254.

PMID: 36707050 PMC: 10258410. DOI: 10.1016/j.tvr.2023.200254.


PML Alternative Splice Products Differentially Regulate HAdV Productive Infection.

Mai J, Stubbe M, Hofmann S, Masser S, Dobner T, Boutell C Microbiol Spectr. 2022; 10(4):e0078522.

PMID: 35699431 PMC: 9431499. DOI: 10.1128/spectrum.00785-22.


Disruption of NBS1/MRN Complex Formation by E4orf3 Supports NF-κB That Licenses E1B55K-Deleted Adenovirus-Infected Cells to Accumulate DNA>4n.

Almuzaini N, Moore M, Robert-Guroff M, Thomas M Microbiol Spectr. 2022; 10(1):e0188121.

PMID: 35019694 PMC: 8754114. DOI: 10.1128/spectrum.01881-21.


Identifying Host Factors Associated with DNA Replicated During Virus Infection.

Reyes E, Kulej K, Pancholi N, Akhtar L, Avgousti D, Kim E Mol Cell Proteomics. 2017; 16(12):2079-2097.

PMID: 28972080 PMC: 5724173. DOI: 10.1074/mcp.M117.067116.


Adenovirus replaces mitotic checkpoint controls.

Turner R, Groitl P, Dobner T, Ornelles D J Virol. 2015; 89(9):5083-96.

PMID: 25694601 PMC: 4403466. DOI: 10.1128/JVI.00213-15.


References
1.
OConnor R, Hearing P . The E4-6/7 protein functionally compensates for the loss of E1A expression in adenovirus infection. J Virol. 2000; 74(13):5819-24. PMC: 112076. DOI: 10.1128/jvi.74.13.5819-5824.2000. View

2.
Kirn D . Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials. Expert Opin Biol Ther. 2001; 1(3):525-38. DOI: 10.1517/14712598.1.3.525. View

3.
Stracker T, Carson C, Weitzman M . Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature. 2002; 418(6895):348-52. DOI: 10.1038/nature00863. View

4.
Garnett C, Erdman D, Xu W, Gooding L . Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol. 2002; 76(21):10608-16. PMC: 136639. DOI: 10.1128/jvi.76.21.10608-10616.2002. View

5.
Mahr J, Boss J, Gooding L . The adenovirus e3 promoter is sensitive to activation signals in human T cells. J Virol. 2002; 77(2):1112-9. PMC: 140835. DOI: 10.1128/jvi.77.2.1112-1119.2003. View